BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)March 25, 2026
Share Facebook Twitter LinkedIn Pinterest Email Marvel's 'Thunderbolts' leads box office for 2nd Week; 'Clown in a Cornfield' sets IFC record
BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)March 25, 2026
Absci outlines $25B annual market potential for ABS-201 in AGA and advances endometriosis clinical program (NASDAQ:ABSI)March 25, 2026